Alveolar macrophage from cigarette smoke-exposed mice inhibits B lymphocyte proliferation stimulated with LPS

Respiration

Volumn 77, Issue 1, 2009, Pages 91-95

  Ishida, T ^a,b   Pinkerton, K E ^c   Takeuchi, M ^a  

^a KYOTO SANGYO UNIVERSITY   (Japan)

^b Club Cosmetics Co Ltd   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alveolar macrophage; B lymphocyte proliferation; Cigarette smoke; Reactive oxygen species

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CIGARETTE SMOKE; DICHLOROFLUORESCEIN; HYDROETHIDINE; HYDROGEN PEROXIDE; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOKING;

ANIMALS; B-LYMPHOCYTES; BRONCHOALVEOLAR LAVAGE FLUID; CATALASE; CELL PROLIFERATION; FEMALE; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; SMOKING; SUPEROXIDE DISMUTASE;

EID: 58249120617     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000170786     Document Type: Article

References (20)

1. Barbour SE, Nakashima K, Zhang JB, Tangada S, Hahn CL, Schenkein HA, Tew JG: Tobacco and smoking. Rev Oral Biol Med 1997;8:437-460.
2. Johnson JD, Hauchens DP, Kluwe WN, Craig DK, Fisher GL: Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol 1990;20:369-395.
3. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD: Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994;150:696-703.
4. Meuronen A, Majuri ML, Alenius H, Mantyla T, Wolff H, Piirila P, Laitinen A: Decreased cytokine and chemokine mRNA expression in bronchoalveolar lavage in asymptomatic smoking subjects. Respiration 2008;75:450-458.
5. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN: Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic pb-structive pulmonary disease. Am J Respir Cell Mol Biol 2007;37:748-755.
6. Proulx LI, Pare G, Bissonnette EY: Alveolar macrophage cytoxic activity is inhibited by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a carcinogenic component of cigarette smoke. Cancer Immunol Immunother 2007;56:831-838.
7. Sopori M: Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002;2:372-377.
8. Takeuchi T, Nagai S, Nakajima A, Shinya M, Tsukano C, Asada H, Yoshikawa K, Yoshimura M, Izumi T: Inhibition of lung natural killer cell activity by smoking. Respiration 2001;68:262-267.
9. Vernooy JH, Dentener MA, van Suylen RJ, Buurman WA, Wouters EF: Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol 2002;26:152-159.
10. Hakki A, Hallquist N, Friedman H, Pross S: Differential impact of nicotine on cellular proliferation and cytokine production by LPS-stimulated murine splenocytes. Int J Immunopharmacol 2000;22:403-410.
11. Hoidal JR, Fox RB, LeMarbe PA, Perri R, Repine JE: Altered oxidative metabolic responses in vitro of alveolar macrophages from aymptomatic cigarette smokers. Am Rev Respir Dis 1981;123:85-89.
12. Nathan C, Shiloh MU: Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathpgens. Proc Natl Acad Sci USA 2000;97:8841-8848.
13. Therriault MJ, Proulx LI, Castonguay A, Bissonnette EY: Immunomodulatory effects of the tobacco-speciffic cartinogen, NNK, on alveolar macrophages. Clin Exp Immunol 2003;132:232-238.
14. Deliconstantinos G, Villiotou V, Stavrides JC: Scavenging effects of hemoglobin and related heme containing compounds on nitric oxide, reactive oxidants and carcinogenic volatile nitrosocompounds of cigarette smoke: a new method for protection against the dangerous cigarette constituents. Anticancer Res 1994;14:2717-2726.
15. Fubini B, Hubbard A: Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med 2003;34:1507-1516.
16. Van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE: Reactive nitrogen species and tyrosine nitration in the respiratory tract. Am J Respir Crit Care Med 1999;160:1-9.
17. Thomassen MJ, Buhrow LT, Conners MJ, Kaneko FT, Erzurum SC, Kavuru MS: Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophage. Am J Respir Cell Mol Biol 1997;17:279-283.
18. Raychaudhuri B, Dweik R, Connors MJ, Buhrow L, Malur A, Drazba J, Arroliga AC, Erzurum SC, Kavuru MS, Thomassen MJ: Nitric oxide blocks nuclear factor κB activation in alveolar macrophages. Am J Respir Cell Mol Biol 1999;21:311-316.
19. Aoshiba K: Role of alveolar cell apoptosis in COPD. Nippon Rinsho 2007;65:629-632.
20. Inoue S, Nakamura H, Otake K, Saito H, Terashita K, Sato J, Takeda H, Tomoike H: Impaired pulmonary inflammatory responses are a prominent feature of streptococcal pneumonia in mice with experimental emphysema. Am J Respir Crit Care Med 2003;167:764-770.